Diality Overview
- Founded
-
2015
- Status
-
Private
- Employees
-
49
- Latest Deal Type
-
Series B2
- Latest Deal Amount
-
$24.9M
- Investors
-
3
Diality General Information
Description
Developer of a hemodialysis machine designed to improve the care and lives of patients with kidney disease. The company's machine is smart, flexible, and portable, and features a degree of automation and a range of hemodialysis modalities among others, enabling patients with kidney disease to conduct dialysis on their own, anywhere and at an affordable price.
Contact Information
Website
www.diality.com
Formerly Known As
EasyDial
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Other Industries
Therapeutic Devices
Other Healthcare Technology Systems
Primary Office
- 181 Technology Drive
- Suite 150
- Irvine, CA 92618
- United States
+1 (949) 000-0000
Diality Timeline
Diality Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series B2) | 31-Mar-2022 | $24.9M | 000.00 | Completed | Generating Revenue | |
| 6. Secondary Transaction - Private | 14-Dec-2020 | 000.00 | Completed | Generating Revenue | ||
| 5. Later Stage VC (Series B) | 20-Oct-2020 | 000.00 | 000.00 | Completed | Generating Revenue | |
| 4. Debt - PPP | 15-Apr-2020 | 00000 | 000.00 | Completed | Generating Revenue | |
| 3. Early Stage VC (Series A) | 13-Aug-2019 | 0000 | 000.00 | Completed | Generating Revenue | |
| 2. Early Stage VC (Series A) | 13-Dec-2018 | $8M | $36.9M | Completed | Generating Revenue | |
| 1. Angel (individual) | $28.9M | $28.9M | Completed | Startup |
Diality Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Diality Patents
Diality Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220378992-A1 | Dialysis system with a dialysate quality sensor | Pending | 31-May-2021 | 0000000000 | |
| US-20220378995-A1 | Methods and systems for controlling dialysate salt concentration | Pending | 31-May-2021 | 0000000000 | |
| AU-2022228106-A1 | Hemodialysis system with variable dialysate flow rate | Pending | 28-May-2021 | 0000000000 | |
| US-20220387684-A1 | Hemodialysis system with variable dialysate flow rate | Pending | 28-May-2021 | 0000000000 | 0 |
| US-20220378994-A1 | Sorbent regeneration cartridge for dialysis | Pending | 28-May-2021 | B01J20/28052 |
Diality Executive Team (10)
Diality Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Aaron Mishkin | Diality | Co-Founder & Board Member | 000 0000 |
| Allen Nissenson MD | Self | Board Member | 000 0000 |
| Martin Pasek | Diality | Board Member | 000 0000 |
| Martin Riediker Ph.D | Diality | Board Member | 000 0000 |
| Timothy Mcnamara Ph.D | Diality | Chief Science Officer, Vice President of Medical Affairs, Scientific Advisor & Board Member | 000 0000 |
Diality Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Diality Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Advent Access | VC-Backed Company | Minority | 000 0000 | 000000 0 | |
| Awak | Corporation | Minority | 000 0000 | 000000 0 | |
| Bellco | Corporation | Minority | 000 0000 | 000000 0 |